Cargando…
Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression
Background: Metformin has been reported to inhibit the growth of various types of cancers, including breast cancer. Yet the mechanisms underlying the anticancer effects of metformin are not fully understood. Growing evidence suggests that metformin's anticancer effects are mediated at least in...
Autores principales: | Zhang, Jiali, Li, Gefei, Chen, Yuan, Fang, Lei, Guan, Chen, Bai, Fumao, Ma, Mengni, Lyu, Jianxin, Meng, Qing H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556649/ https://www.ncbi.nlm.nih.gov/pubmed/28819383 http://dx.doi.org/10.7150/jca.19858 |
Ejemplares similares
-
Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2
por: Chen, Yuan, et al.
Publicado: (2017) -
Synergistic inhibition of colon cancer growth by the combination of methylglyoxal and silencing of glyoxalase I mediated by the STAT1 pathway
por: Chen, Yuan, et al.
Publicado: (2017) -
A novel RNA sequencing‐based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma
por: Bai, Fumao, et al.
Publicado: (2018) -
Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms
por: Li, Chunmei, et al.
Publicado: (2018) -
CRKL oncogene is downregulated by p53 through miR-200s
por: Tamura, Miyuki, et al.
Publicado: (2015)